Selexipag for the Treatment of Pulmonary Arterial Hypertension - Sitbon, Olivier; Channick, Richard; Chin, Kelly M; Frey, Aline; Gaine, Sean; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M; Lang, Irene M; Preiss, Ralph; Rubin, Lewis J; Di Scala, Lilla; et al. (The New England journal of medicine, 2015)
Keywords: Acetamides - adverse effects; Acetamides - therapeutic use; Aged; Circulatory system; Clinical trials; Committees; Diarrhea; Disease Progression; Double-Blind Method; Double-blind studies; Drug Administration Schedule; Drug dosages; Drug therapy; Endothelins; Fees & charges; Female; Headache; Hospitalization - statistics & numerical data; Humans; Hypertension; Hypertension, Pulmonary - complications; Hypertension, Pulmonary - drug therapy; Hypertension, Pulmonary - mortality; Jaw; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Pain; Patients; Pharmaceuticals; Phosphodiesterase; Prodrugs - adverse effects; Prodrugs - therapeutic use; Prostacyclin; Pulmonary arteries; Pulmonary hypertension; Pyrazines - adverse effects; Pyrazines - therapeutic use; Statistical analysis; Substance abuse treatment